The role of viruses in neurodegenerative and neurobehavioral diseases

CNS and Neurological Disorders - Drug Targets

Volumn 13, Issue 7, 2014, Pages 1213-1223

  Karim, Sajjad ^a   Mirza, Zeenat ^a   Kamal, Mohammad A ^a   Abuzenadah, Adel M ^a   Azhar, Esam I ^a   Al Qahtani, Mohammed H ^a   Damanhouri, Ghazi A ^a   Ahmad, Fahim ^b   Gan, Siew H ^c   Sohrab, Sayed S ^a  

^a KING ABDULAZIZ UNIVERSITY   (Saudi Arabia)

^b UNIVERSITY OF TEXAS AT EL PASO   (United States)

^c SCHOOL OF MEDICAL SCIENCES   (Malaysia)

Author keywords

Alzheimer s disease; Amyotrophic lateral sclerosis; HIV associated neurocognitive disorders; Multiple sclerosis; Neurodegenerative diseases; Parkinson s disease; Virus

Indexed keywords

BETA INTERFERON;

ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; AUTISM; BORNA DISEASE VIRUS; CYTOMEGALOVIRUS; DEGENERATIVE DISEASE; DISEASE ASSOCIATION; ENTEROVIRUS; EPSTEIN BARR VIRUS; HEPATITIS VIRUS; HERPES SIMPLEX VIRUS; HIV ASSOCIATED DEMENTIA; HUMAN; IMMUNE SYSTEM; INFLAMMATION; INFLUENZA VIRUS; INFLUENZA VIRUS A H5N1; MENTAL DISEASE; MULTIPLE SCLEROSIS; NERVE CELL DEGENERATION; NONHUMAN; PARKINSON DISEASE; PICORNAVIRUS; ROSEOLOVIRUS; VARICELLA ZOSTER VIRUS; VIRUS INFECTION; VIRUS PATHOGENESIS; VIRUS TRANSMISSION; WEST NILE FLAVIVIRUS; ANIMAL; PATHOPHYSIOLOGY; VIROLOGY;

ANIMALS; HUMANS; MENTAL DISORDERS; NEURODEGENERATIVE DISEASES;

EID: 84911396470     PISSN: 18715273     EISSN: 19963181     Source Type: Journal    
DOI: 10.2174/187152731307141015122638     Document Type: Article

References (154)

1. Zhou L, Monica Miranda-Saksena, Nitin K Saksena. Viruses and neurodegeneration. Virol J 2013; 10: 172.
2. Keen D, Ward S. Autistic spectrum disorder. Autism 2004; 8: 39-58.
3. Bertram L, Tanzi RE. The genetic epidemiology of neurodegenerative disease. J Clin Investig 2005; 115: 1449-57.
4. Mirza Z, Kamal MA, Abuzenadah AM, Al-Qahtani MH, Karim S. Establishing genomic/transcriptomic links between Alzheimer's disease and type II diabetes mellitus by meta-analysis approach. CNS Neurol Disord Drug Targets 2014; 13: 30.
5. Nicolson GL, Gan R, Nicolson NL, et al. Evidence for Mycoplasma, Chlamydia pneunomiae and HHV-6 Co-infections in the blood of patients with Autism Spectrum Disorders. J Neuroscience Res 2007; 85: 1143-8.
6. Griffin WS. Inflammation and neurodegenerative diseases. Am J Clin Nutr 2006; 83: S470-S474.
7. Kern JK, Jones AM. Evidence of toxicity, oxidative stress and neuronal insult in autism. J Toxicol Environ Health B Crit Rev 2006; 9: 485-99.
8. Larsson HJ, Eaton WW, Madsen KM, et al. Risk factors for autism: Perinatal factors, parental psychiatric history and socioeconomic status. Am J Epidemiol 2005; 101: 916-25.
9. Muravchick S, Levy RJ. Clinical implications of mitochondrial dysfunction. Anesthesiology 2006; 105: 819-37.
10. Nicolson GL. Chronic Bacterial and Viral Infections in Neurodegenerative and Neurobehavioral Diseases. Labmedicine 2008; 39 (5): 291-9.
11. Shi J, Levinson DF, Duan J, et al. Common variants onchromosome 6p22.1 are associated with schizophrenia. Nature 2009; 460: 753-7.
12. Zhou Li, Diefenbach Eve, Crossett Ben, et al. First evidence of overlaps between HIV Associated Dementia (HAD) and non-viral neurodegenerative diseases: proteomic analysis of the frontal cortex from HIV+ patients with and without dementia. Mol Neurodegener 2010; 5: 27.
13. Amor S, Puentes F, Baker D, van der Valk P. Inflammation in neurodegenerative diseases. Immunology 2010; 129: 154-69.
14. Mattson MP. Infectious agents and age-related neurodegenerative disorders. Ageing Res Rev 2004; 3: 105-20.
15. Bazala E, Renda J. Latent chlamydial infections: the probable cause of a wide spectrum of human diseases. Med Hypotheses 2005; 65: 578-84.
16. Karim S, Mirza Z, Kamal MA, et al. An Association of Virus Infection with Type 2 Diabetes and Alzheimer’s Disease CNS Neurol Disord Drug Targets 2014; 13: 429-39.
17. Ghoshal A, Das S, Ghosh S, et al. Proinflammatory mediators released by activated microglia induces neuronal death in Japanese encephalitis. Glia 2007; 55: 483-96.
18. Deleidi Michela, Isacson Ole. Viral and Inflammatory Triggers of Neurodegenerative Diseases 2012; Trans Med 121: 1-5.
19. Berth S H, Leopold PL, Morfini GN. Virus-induced neuronal dysfunction and degeneration. Front. Biosci 2009; 14: 5239-5259.
20. Rasool M, Malik A, Qureshi MS, et al. Recent updates in the treatment of neurodegenerative disorders using natural compounds. Evid Based Compl Altern Med 2014; 2014: 979730.
21. Bonin-Guillaume S, Zekry D, Giacobini E, Gold G, Michel JP. The economical impact of dementia. Press Med 2005; 34: 35-41.
22. Carter CJ. Familial and late-onset Alzheimer’s disease: Evidence for an auto-immune component triggered by viral, microbial and allergen antigens with homology to beta-amyloid and APP mutant peptides. Nat Preced 2010b; 1: 4662.
23. Zhang C, Cai Z, Kim YC, et al. Stimulation of hepatitis C virus (HCV) nonstructural protein 3(NS3) helicase activity by the NS3 protease domain and by HCV RNA-dependent RNA polymerase. J Virol 2005; 79: 8687-97.
24. Deans E. Nutrition and Alzheimer's Disease-Dangers of Insulin Resistance and Low Cholesterol. Evol Psychiatry 2011; http://evolutionarypsychiatry.blogspot.com/2011/06/nutrition-andalzheimers-disease.html
25. Miklossy J. Alzheimer's disease-a neurospirochetosis. Analysis of the evidence following Koch's and Hill's criteria. J Neuroinflammation 2011; 8: 90.
26. Allison ME, Wreghitt T, Palmer CR, Alexander GJ. Evidence for alink between hepatitis C virus infection and diabetes mellitus in a cirrhotic population. J Hepatol 1994; 21: 1135-9.
27. Chiu SL, Chen CM, Cline HT. Insulin receptor signaling regulates synapse number, dendritic plasticity, and circuit function in vivo. Neuron 2008; 58: 708-19.
28. Denaro FJ, Staub P, Colmer J, Freed DM. Co-existence of Alzheimer’s Disease neuropathology with Herpes Simplex encephalitis. Cell Mol Biol 2003; 49: 1233-40.
29. Xu F, Lee FK, Morrow RA. Seroprevalence of herpes simplex virus type 1 in children in the United States. J Pediatr 2007; 151(4): 374-7.
30. De Chiara G, Marcocci ME, Sgarbanti R, et al. Infectious Agents and Neurodegeneration. Mol Neurobiol 2012; 46: 614-38.
31. Toma HS, Murina AT, Areaux RG Jr, et al. Ocular HSV-1 latency, reactivation and recurrent disease. Sem Ophthalmol 2008; 23: 249-73.
32. Al-Dujaili LJ, Clerkin PP, Clement C, et al. Ocular herpes simplex virus: How are latency, reactivation, recurrent disease and therapy interrelated? Fut Microbiol 2011; 6: 877-907.
33. Carter CJ. Alzheimer’s Disease: A Pathogenetic Autoimmune Disorder Caused by Herpes Simplex in a Gene-Dependent Manner. Int J Alzheimers Dis 2010a; 140539.
34. Wozniak MA, Frost AL, Itzhaki RF. Alzheimer’s disease-specific tau phosphorylation is induced by herpes simplex virus type 1. J Alzheimers Dis 2009; 16(2): 341-50.
35. Itzhaki RF, Dobson CB, Wozniak MA. Herpes simplex virus type 1and Alzheimer’s disease. Ann Neurol 2004; 55: 299-300.
36. Cheng SB, Ferland P, Webster P, Bearer EL. Herpes simplex virus dances with amyloid precursor protein while exiting the cell. PLoS One 2011; 6(3): e17966.
37. Wozniak MA, Frost, AL, Preston CM, Itzhaki RF. Antivirals reduce the formation of key Alzheimer’s disease molecules in cell cultures acutely infected with herpes simplex virus type 1. PLoS One 2011; 6 (10): e25152.
38. Kammerman EM, Neumann DM, Ball MJ, Lukiw W, Hill JM. Senile plaques in Alzheimer’s disease brains: Possible association of beta amyloid with herpes simplex virus type 1 (HSV-1) Lparticles. Med Hypotheses 2006; 66: 294-9.
39. Meckes DG Jr, Raab TN. Microvesicles and viral infection. J Virol 2011; 85: 12844-54.
40. Bearer EL. HSV-axonal transport and Alzheimer’s disease: in vitro and in vivo evidence for causal relationships. Fut Virol 2012; 7(9): 885-99.
41. Li YY, Cui JG, Hill JM, et al. Increased expression of miRNA-146a in Alzheimer’s disease transgenic mouse models. Neuro sci Lett 2011; 487: 94-8.
42. Lukiw WJ, Cui JG, Yuan LY, et al. Acyclovir or A [beta] 42 peptides attenuate HSV-1-induced miRNA-146a levels in human primary brain cells. Neuro Report 2010; 21: 922-7.
43. Ball MJ, Lukiw WJ, Kammerman EM, Hill JM. Intracerebral propagation of Alzheimer's disease: strengthening evidence of a herpes simplex virus etiology. Alzheimers Dement 2012; (12): 1552-5260.
44. WHO. Cumulative Number of Confirmed Human Cases for Avian Influenza A/(H5N1) Reported to WHO 2013; 2003-2011.
45. Jellinger KA. Neuropathological aspects of Alzheimer disease, Parkinson disease and frontotemporal dementia. Neurodegener Dis 2008; 5: 118-21.
46. Tansey MG, Frank-Cannon TC, McCoy MK, et al. Neuroinflammation in Parkinson’s disease: Is there sufficient evidence for mechanism-based interventional therapy? Front Biosci 2008; 1(13): 709-17.
47. Jang H, Boltz D, Sturm-Ramirez K, et al. Highly pathogenic H5N1 influenza virus can enter the central nervous system and induce neuroinflammation and neurodegeneration. Proc Natl Acad Sci USA 2009; 106(33): 14063-8.
48. Ryan KJ, Ray CG. Sherris Medical Microbiology; 4th edn.; McGraw Hill; New york 2004; pp. 566-9.
49. Koichi Y, Arvin AM, Gabriella C, et al. Human herpesviruses: biology, therapy, and immunoprophylaxis. Cambridge, UK: Cambridge University Press 2007.
50. Offermanns S, Rosenthal W. Encyclopedia of Molecular Pharmacology (2nd ed.) 2008; Springer. 437-438.
51. Lin WR, Wozniak MA, Cooper RJ, et al. Herpes viruses in brain and Alzheimer’s disease. J Pathol 2002; 197: 395-402.
52. Itzhaki RF, Lin WR, Shang D, et al. Herpes simplex virus type 1 in brain and risk of Alzheimer’s disease. Lancet 1997; 349: 241-4.
53. Martinez ES, Saiz M, Sobrino F. Foot-and-Mouth Disease Virus Mol Biol 2008; 22-6.
54. Charles H. Alzheimer's disease linked to the common cold. Mail Online 2006; p: 1. http://www.dailymail.co.uk/health/article-412145/Alzheimers-disease-linked-common-cold.html
55. Ludwig H, Bode L. Borna Disease Virus: new aspects on infection, disease, diagnosis and epidemiology. Rev Sci Tech Off Int Epiz 2000; 19(1): 259-88.
56. Volmer R, Prat CM, Le Masson G, Garenne A, Gonzalez-Dunia D. Borna Disease Virus Infection Impairs Synaptic Plasticity. J Virol 2007; 81(16): 8833-7.
57. Honjo K, van Reekum R, Verhoeff NP. Alzheimer's disease and infection: do infectious agents contribute to progression of Alzheimer's disease? Alzheimers Dement 2009; 5(4): 348-60.
58. Sylva R, Lubos J. Borna disease virus and Psychiatric Disorders: Can Viruses Influence Psychiatric Disorders? Psychiatric Disord Worldwide Adv 2011; 307: 833-5.
59. Wolters EC, Braak H. Parkinson’s disease: premotor clinicopathological correlations. J Neural Transm 2006; 70(Suppl): 309-19.
60. Tabrez S, Jabir NR, Shakil S, et al. A Synopsis on the Role of Tyrosine Hydroxylase in Parkinson's Disease. CNS Neurol Disord Drug Targets 2012; 11(4): 395-409.
61. Obeso JA, Rodríguez-Oroz MC, Benitez-Temino B, et al. M. Functional organization of the basal ganglia: therapeutic implications for Parkinson’s disease. Mov Disord 2008; 23(Suppl 3): S548-59.
62. Sulzer D. Multiple hit hypothesis for dopamine neuron loss in Parkinson’s disease. Trends Neurosci 2007; 30: 244-50.
63. Klopfleisch R, Werner O, Mundt E, Harder T, Teifke JP. Neurotropism of highly pathogenic avian influenza virus A/chicken/Indonesia/2003(H5N1) in experimentally infected pigeons (Columbia livia f. domestica). Vet Pathol 2006; 43: 463-70.
64. Rigoni M, Shinya K, Toffan A, et al. Pneumo-and neurotropism of avian origin Italian highly pathogenic avian influenza H7N1 isolates in experimentally infected mice. Virology 2007; 364: 28-35.
65. Rimmelzwaan GF, van Riel D, Baars M, et al. Influenza A virus (H5N1) infection in cats causes systemic disease with potential novel routes of virus spread within and between hosts. Am J Pathol 2006; 168: 176-83.
66. Influenza WHO Fact Sheet No. 211. Revised March 2003. 2006.
67. Ravenholt RT, Foege WH.1918 influenza, encephalitis lethargica, parkinsonism. Lancet 1982; 2: 860-4.
68. Martyn CN, Osmond C. Parkinson’s disease and the environment in earlylife. J Neurol Sci 1995; 132: 201-6.
69. Gambotto A, Barratt-Boyes SM, de Jong MD, et al. Human infection with highly pathogenic H5N1 influenza virus. Lancet 2008; 371: 1464-75.
70. Jang H, Boltz D, Sturm-Ramirez K, et al. Highly pathogenic H5N1 influenza virus can enter the centralnervous system and induce neuroinflammation and neurodegeneration.Proc Natl Acad Sci USA 2009; 106: 14063-8.
71. Takahashi M, Yamada T, Nakajima S, et al. The substantia nigra is a major target for neurovirulent influenza A virus. J Exp Med 1995; 181: 2161-9.
72. Jang H, Boltz D, McClaren J, et al. Smeyne, Inflammatory effects of highly pathogenic H5N1 influenza virus infection in the CNS of mice. J Neurosci 2012; 32: 1545-59.
73. Rohn TT, Catlin LW. Immunolocalization of influenza A virus and markers of inflammation in the human Parkinson’s disease brain. PLoS One 2011; 6: e20495.
74. Shoji H, Watanabe M, Itoh S, et al. Japanese encephalitis and parkinsonism. J Neurol 1993; 240: 59-60.
75. Zlokovic BV. The Blood-Brain Barrier in Health and Chronic Neurodegenerative Disorders. Neuron 2008; 57(2): 178-201.
76. Bruck W. Clinical implications of neuropathological findings in multiple sclerosis. J Neurol 2005; 252: S10-4.
77. Swanborg RH, Whittum-Hudson JA, Hudson AP. Infectious agents and multiple sclerosis - Are Chlamydia pneumoniae and human herpes virus 6 involved? J Neuroimmunol 2003; 136: 1-8.
78. Sanders VJ, Felisan S, Waddell A, Tourtellotte WW. Detection of herpes virus in postmortem multiple sclerosis brain tissue and controls by polymerase chain reaction. J Neuro Virol 1996; 2: 249-58.
79. Sola P, Merelli E, Marasca R, et al. Human herpesvirus-6 and multiple sclerosis: survey of anti-HHV-6 antibodies by immunofluorescence analysis and viral sequences by polymerase chain reaction. J Neurol Neurosurg Psychiatry 1993; 56: 917-9.
80. Pietropaolo V, Fioriti D, Mischitelli M, et al. Detection of human herpesviruses and polyomaviruses in a group of patients with relapsing remitting multiple sclerosis. New Microbiol 2005; 28: 199-203.
81. Haahr S, Sommerlund M, Christensen T, et al. A putative new retrovirus associated with multiple sclerosis and the possible involvement of Epstein-Barr virus in this disease. Ann NY Acad Sci 1994; 724: 148-56.
82. Jaworska J, Gravel A, Flamand L. Divergent susceptibilities of human herpesvirus 6 variants to type I interferons. Proc Natl Acad Sci USA 2010; 107: 8369-74.
83. Alvarez-Lafuente R, Garcia-Montojo M, De Las Heras V, et al. Herpesviruses and human endogenous retroviral sequences in the cerebrospinal fluid of multiple sclerosis patients. Mult Scler 2008; 14: 595-601.
84. Garcia-Montojo M, De Las Heras V, Dominguez-Mozo M, et al. Human herpesvirus 6 and effectiveness of interferon beta 1b in multiple sclerosis patients. Eur J Neurol 2011; 18: 1027-35.
85. Vandenbroeck K, Alloza I, Swaminathan B, et al. Validation of IRF5 as multiple sclerosis risk gene: putative role in interferon beta therapy and human herpes virus-6 infection. Genes Immun 2011; 12: 40-5.
86. Fraser KB, Haire M, Millar JH, McCrea S. Increased tendency to spontaneous in-vitro lymphocyte transformation in clinically active multiple sclerosis. Lancet 1979; 2: 175-6.
87. Levin LI, Munger KL, O'Reilly EJ, Falk KI, Ascherio A. Primary infection with the Epstein-Barr virus and risk of multiple sclerosis. Ann Neurol 2010; 67: 824-30.
88. Santiago O, Gutierrez J, Sorlozano A, et al. Relation between Epstein-Barr virus and multiple sclerosis: analytic study of scientific production. Eur J Clin Microbiol Infect Dis 2010; 29: 857-66.
89. Munger KL, Levin LI, O'Reilly EJ, Falk KI, Ascherio A. Anti-Epstein-Barr virus antibodies as serological markers of multiple sclerosis: a prospective study among United States military personnel. Mult Scler 2011; 17: 1185-93.
90. Gulley ML, Tang W. Laboratory assays for Epstein-Barr virusrelated disease. J Mol Diagn 2008; 10: 279-92.
91. Hadinoto V, Shapiro M, Sun CC, et al. The dynamics of EBV shedding implicate a central role for epithelial cells in amplifying viral output. PLoS Pathog 2009; 5: e1000496.
92. Lassmann H, Niedobitek G, Aloisi F, Middeldorp JM. Epstein-Barr virus in the multiple sclerosis brain: a controversial issue–report on a focused workshop held in the Centre for Brain Research of the Medical University of Vienna, Austria. Brain 2011; 134: 2772-86.
93. Sargsyan SA, Shearer AJ, Ritchie AM, et al. Absence of Epstein-Barr virus in the brain and CSF of patients with multiple sclerosis. Neurology 2010; 74: 1127-35.
94. Serafini B, Muzio L, Rosicarelli B, Aloisi F. Radioactive in situ hybridization for Epstein-Barr virus-encoded small RNA supports presence of Epstein-Barr virus in the multiple sclerosis brain. Brain 2013; 1093: e1-6.
95. Kang JH, Sheu JJ, Kao S, Lin HC. Increased risk of multiple sclerosis following herpes zoster: a nationwide, population-based study. J Infect Dis 2011; 204: 188-92.
96. Perez-Cesari C, Saniger MM, Sotelo J. Frequent association of multiple sclerosis with varicella and zoster. Acta Neurol Scand 2005; 112: 417-9.
97. Sotelo J, Martínez-Palomo A, Ordoñez G, Pineda B. Varicellazoster virus in cerebrospinal fluid at relapses of multiple sclerosis. Ann Neurol 2008, 63: 303-11.
98. Pineda BSM, María-Elena Chánez-Cárdenas, José-Manuel Saniger. Solid-phase assay for the detection of varicella zoster virus. Fut Virol 2009; 4: 9.
99. Ordoñez G, Martinez-Palomo A, Corona T, et al. Varicella zoster virus in progressive forms of multiple sclerosis. Clin Neurol Neurosurg 2010; 112: 653-7.
100. Burgoon MP, Cohrs RJ, Bennett JL, et al. Varicella zoster virus is not a disease relevant antigen in multiple sclerosis. Ann Neurol 2009; 65(4): 474-9.
101. Berger MM, Kopp N, Vital C, et al. Detection and cellular localization of enterovirus RNA sequences in spial cord of patients with ALS. Neurology 2000; 54: 20-5.
102. Nix WA, Berger MM, Oberste MS, et al. Failure to detect enterovirus in the spinal cord of ALS patients using a sensitive RTPCR method. Neurology 2004; 62: 1372-7.
103. Andrews WD, Tuke PW, Al-Chalabi A, et al. Detection of reverse transcriptase activity in the serum of patients with motorneurone disease. J Med Virol 2000; 61: 527-32.
104. Verma A, Berger JR. ALS syndrome in patients with HIV-1 infection. J Neurol Sci 2006; 240: 59-64.
105. McCormick AL, Brown RH Jr, Cudkowicz ME, et al. Quantification of reverse transcriptase in ALS and elimination of a novel retroviral candidate. Neurology 2008; 70: 278-83.
106. Williams DB, Windebank AJ. Motor neuron disease (Amyotrophic Lateral Sclerosis). Mayo Clin Proc 1991; 66: 54-82.
107. Steele AJ, Al-Chalabi A, Ferrante K, et al. Detection of serum reverse transcriptase activity in patients with ALS and unaffected blood relatives. Neurology 2005, 64: 454-8.
108. MacGowan DJ, Scelsa SN, Imperato TE, et al. A controlled study of reverse transcriptase in serum and CSF of HIV negative patients with ALS. Neurology 2007; 68: 1944-6.
109. Douville R, Liu J, Rothstein J, Nath A. Identification of active loci of a human endogenous retrovirus in neurons of patients with amyotrophic lateral sclerosis. Ann Neurol 2011; 69: 141-51.
110. Libbey JE, Sweeten TL, McMahon WM, Fujinami RS. Autistic disorder and viral infections. J Neurovirol 2005; 11: 1-10.
111. Shinya K, Shimada A, Ito T, et al. Avian influenza virus intra nasally inoculated infects the central nervous system of mice through the general visceral afferent nerve. Arch Virol 2000, 145: 187-95.
112. Zhou L, Rua R, Ng T, et al. Evidence for predilection of macrophage infiltration patterns in the deeper midline and mesial temporal structures of the brain uniquely in patients with HIVassociated dementia. BMC Infect Dis 2009; 9: 192.
113. Schnell G, Joseph S, Spudich S, Price RW, Swanstrom R. HIV-1 replication in the central nervous system occurs in two distinct cell types. PLoS Pathog 2011; 7: e1002286.
114. Kumar AM, Ownby RL, Waldrop-Valverde D, Fernandez B, Kumar M. Human immunodeficiency virus infection in the CNS and decreased dopamine availability: relationship with neuropsychological performance. J Neurovirol 2011; 17: 26-40.
115. Zhou L, Pupo GM, Gupta P, et al. A parallel genome-wide mRNA and microRNA profiling of the frontal cortex of HIV patients with and without HIV-associated dementia shows the role of axon guidance and downstream pathways in HIV-mediated neurodegeneration. BMC Genom 2012; 13: 677.
116. Yang WX, Terasaki T, Shiroki K, et al. Efficient delivery of circulating poliovirus to the central nervous system independently of poliovirus receptor. Virology 1997; 229: 421-8.
117. Iwasaki T, Itamura S, Nishimura H, et al. Productive infection in the murine central nervous system with avian influenza virus A (H5N1) after intranasal inoculation. Acta Neuropathol 2004; 108: 485-92.
118. Harberts E, Yao K, Wohler JE, et al. Human herpesvirus-6 entry into the central nervous system through the olfactory pathway. Proc Natl Acad Sci USA 2011; 108: 13734-9.
119. Crutcher KA, Gendelman HE, Kipnis J, et al. Debate: “is increasing neuroinflammation beneficial for neural repair?” J Neuroimmune Pharmacol 2006; 1: 195-211.
120. Popovich PG, Longbrake EE. Can the immune system be harnessed to repair the CNS? Nat Rev Neurosci 2008; 9: 481-93.
121. Block ML, Hong JS. Microglia and inflammation-mediated neurodegeneration: multiple triggers with a common mechanism. Prog Neurobiol 2005; 76: 77-98.
122. McGeer EG, McGeer PL. The role of anti-inflammatory agents in Parkinson’s disease. CNS Drugs 2007; 21: 789-97.
123. Nagatsu T, Sawada M. Cellular and molecular mechanisms of Parkinson’s disease: neurotoxins, causative genes, and inflammatory cytokines. Cell Mol Neurobiol 2006; 26: 781-802.
124. Mrak RE, Griffin WS. Glia and their cytokines in progression of neurodegeneration. Neurobiol Aging 2005; 26: 349-54.
125. Abrahams A. Discussion on Influenza. Proc R Soc Med 1919; 12: 97-102.
126. Neustadt RE. HVF: The swine flu Affair: decision making on a Slippery disease. Washington: D.C.U.S. Department of Health, Education, and Welfare; 1978.
127. Zimmer SM, Burke DS. Historical perspective–Emergence of influenza A (H1N1) viruses. N Engl J Med 2009; 361: 279-85.
128. Kapila CC, Kaul S, Kapur SC, et al. Neurological and hepatic disorders associated with influenza. Br Med J 1958; 2: 1311-4.
129. Hayase Y, Tobita K. Influenza virus and neurological diseases. Psychiatry Clin Neurosci 1997; 51(4): 181-4.
130. Toovey S. Influenza-associated central nervous system dysfunction: a literature review. Travel Med Infect Dis 2008; 6(3): 114-24.
131. Fazzini E, Fleming J, Fahn S. Cerebrospinal fluid antibodies to coronavirus in patients with Parkinson’s disease. Mov Disord 1992; 7: 153-8.
132. Pranzatelli MR, Mott SH, Pavlakis SG, Conry JA, Tate ED. Clinical spectrum of secondary parkinsonism in childhood: a reversible disorder. Pediatr Neurol 1994; 10: 131-40.
133. Cerna F, Mehrad B, Luby JP, Burns D, Fleckenstein JL. St. Louis encephalitis and the substantia nigra: MR imaging evaluation. Am J Neuroradiol 1999; 20: 1281-3.
134. Nielsen NM, Rostgaard K, Hjalgrim H, Aaby P, Askgaard D. Poliomyelitis and Parkinson disease. JAMA 2002; 287: 1650-1.
135. Wüthrich C, Dang X, Westmoreland S, et al. Fulminant JC virus encephalopathy with productive infection of cortical pyramidal neurons. Ann Neurol 2009, 65: 742-8.
136. Misra U, Kalita J. Prognosis of Japanese encephalitis patients with dystonia compared to those with parkinsonian features only. Postgrad Med J 2002; 78(918): 238-41.
137. Mégret F, Prehaud C, Lafage M, et al. Modulation of HLA-G and HLA-E expression in human neuronal cells after rabies virus or herpes virus simplex type 1 infections. Hum Immunol 2007; 68: 294-302.
138. Brettschneider J, Tumani H, Kiechle U, et al. IgG antibodies against measles, rubella and varicella zoster virus predict conversion to multiple sclerosis in clinically isolated syndrome. PLoS ONE 2009; 4: e7638.
139. Zivadinov R, Zorzon M, Weinstock-Guttman B, et al. Epstein-Barr virus is associated with grey matter atrophy in multiple sclerosis. J Neurol Neurosurg Psychiatry 2009; 80: 620-5.
140. Lünemann JD, Tintoré M, Messmer B, et al. Elevated Epstein–Barr virus encoded nuclear antigen-1 immune responses predict conversion to multiple sclerosis. Ann Neurol 2010; 67; 159-69.
141. Oger J. HTLV-1 infection and the viral etiology of multiple sclerosis. J Neurol Sci 2007; 262: 100-4.
142. Perron H, Suh M, Lalande B, et al. Herpes simplex virus ICP0 and ICP4 immediate early proteins strongly enhance expression of a retrovirus harbored by a leptomeningeal cell line from a patient with multiple sclerosis. J Gen Virol 1993; 74; 65-72.
143. Liebert UG. Measles virus infections of the central nervous system. Intervirology 1997; 40: 176-84.
144. Fujinami RS, Oldstone MB, Wroblewska Z, Frankel ME, Koprowski H. Molecular mimicry in virus infection: crossreaction of Measles virus phosphoprotein or of herpes simplex virus protein with human intermediate filaments. Proc Natl Acad Sci USA 1983; 80: 2346-50.
145. Ahlgren C, Oden A, Berstromg T, Lycke J. Serum and CSF measles antibody levels increase over time in multiple sclerosis or clinically isolated syndrome. J Neuroimmunol 2012; 247: 70-4.
146. Tobler LH, Johnson KP, Case Buerhing G. Measles or mumps virus-infected cells forming rosettes with lymphocytes from patients with multiple sclerosis. Arch Neurol 1982; 39: 565-9.
147. Rauch HC, King KM, Lewandowski LJ. Detection of cellular hypersensitivity among multiple sclerosis (MS) patients to 6/94 virus; a parainfluenza type-1 isolate from MS brain tissue. Int Arch Allergy Appl Immunol 1975; 48: 475-84.
148. Haile R, Smith P, Read D, et al. A study of measles virus and canine distemper virus antibodies, and of childhood infections in multiple sclerosis patients and controls. J Neurol Sci 1982; 56: 1-10.
149. Goswami KK, Lange LS, Mitchell DN, Cameron KR, Russell WC. Does simian virus 5 infect humans? J Gen Virol 1984; 65: 1295-303.
150. Boucher A, Desforges M, Duquette P, Talbot PJ. Long-term human coronavirus-myelin cross-reactive T-cell clones derived from multiple sclerosis patients. Clin Immunol 2007; 23: 258-67.
151. Ho M. Enterovirus 71: The virus, its infections and outbreaks. J Microbiol Immunol Infect 2000; 33: 205-16.
152. Ince PG, Codd GA. Return of the cycad hypothesis-Does the amyotrophic lateral sclerosis/parkinsonism dementia complex (ALS/PDC) of Guam have new implications for global health? Neuropathol Appl Neurobiol 2005; 31: 345-53.
153. Matsuzaki T, Nakagawa M, Nagai M, et al. HTLV-I-associated myelopathy (HAM)/tropical spastic paraparesis (TSP) with amyotrophic lateral sclerosis-like manifestations. J Neurovirol 2000; 6: 544-8.
154. Ekstrand JJ. Neurologic complications of influenza. Semin Pediatr Neurol 2012; 19 (3): 96-100.